N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide

C49H57FN8O8 — CID 162659651

IUPACN-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide
SMILESO=C(CCCCCCCCCCCCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1)NCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C49H57FN8O8/c50-37-21-20-32(31-39-33-14-11-12-15-34(33)45(62)55-54-39)30-36(37)47(64)57-28-26-56(27-29-57)43(61)19-10-8-6-4-2-1-3-5-7-9-18-41(59)52-25-24-51-38-17-13-16-35-44(38)49(66)58(48(35)65)40-22-23-42(60)53-46(40)63/h11-17,20-21,30,40,51H,1-10,18-19,22-29,31H2,(H,52,59)(H,55,62)(H,53,60,63)
InChIKeyWTSVLYSMIRPZJM-UHFFFAOYSA-N
MW905.04 g/mol
LogP5.25
Rot. Bonds21

About N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide

N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide (PubChem CID 162659651) has the molecular formula C49H57FN8O8 and a molecular weight of 905.04 g/mol. Its IUPAC name is N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide.

Molecular Properties

Compound NameN-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide
PubChem CID162659651
Molecular FormulaC49H57FN8O8
Molecular Weight905.04 g/mol
Exact Mass904.43
IUPAC NameN-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide
SMILESO=C(CCCCCCCCCCCCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1)NCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C49H57FN8O8/c50-37-21-20-32(31-39-33-14-11-12-15-34(33)45(62)55-54-39)30-36(37)47(64)57-28-26-56(27-29-57)43(61)19-10-8-6-4-2-1-3-5-7-9-18-41(59)52-25-24-51-38-17-13-16-35-44(38)49(66)58(48(35)65)40-22-23-42(60)53-46(40)63/h11-17,20-21,30,40,51H,1-10,18-19,22-29,31H2,(H,52,59)(H,55,62)(H,53,60,63)
InChIKeyWTSVLYSMIRPZJM-UHFFFAOYSA-N
XLogP5.25
TPSA211.05 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds21
Heavy Atoms66
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500905.04
LogP ≤ 55.25
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide?
The IUPAC name of N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide (CID 162659651) is N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide.
What is the SMILES notation for N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide?
The canonical SMILES for N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide is O=C(CCCCCCCCCCCCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1)NCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.
What is the InChIKey of N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide?
The InChIKey is WTSVLYSMIRPZJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H57FN8O8/c50-37-21-20-32(31-39-33-14-11-12-15-34(33)45(62)55-54-39)30-36(37)47(64)57-28-26-56(27-29-57)43(61)19-10-8-6-4-2-1-3-5-7-9-18-41(59)52-25-24-51-38-17-13-16-35-44(38)49(66)58(48(35)65)40-22-23-42(60)53-46(40)63/h11-17,20-21,30,40,51H,1-10,18-19,22-29,31H2,(H,52,59)(H,55,62)(H,53,60,63).
What are the key properties of N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide?
N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide has a molecular weight of 905.04 g/mol, XLogP of 5.25, 21 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-14-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-14-oxotetradecanamide is sourced from PubChem (CID 162659651), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).